FR2916352B1 - USE OF A NON-PEPTIDE ANTAGONIST OF BRADYKININ B1 RECEPTOR FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE PREVENTION OR TREATMENT OF ARTERIAL HYPERTENSION. - Google Patents

USE OF A NON-PEPTIDE ANTAGONIST OF BRADYKININ B1 RECEPTOR FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE PREVENTION OR TREATMENT OF ARTERIAL HYPERTENSION.

Info

Publication number
FR2916352B1
FR2916352B1 FR0703663A FR0703663A FR2916352B1 FR 2916352 B1 FR2916352 B1 FR 2916352B1 FR 0703663 A FR0703663 A FR 0703663A FR 0703663 A FR0703663 A FR 0703663A FR 2916352 B1 FR2916352 B1 FR 2916352B1
Authority
FR
France
Prior art keywords
bradykinin
receptor
prevention
preparation
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0703663A
Other languages
French (fr)
Other versions
FR2916352A1 (en
Inventor
Pierre Carayon
Wolfgang Linz
Rejean Couture
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Priority to FR0703663A priority Critical patent/FR2916352B1/en
Publication of FR2916352A1 publication Critical patent/FR2916352A1/en
Application granted granted Critical
Publication of FR2916352B1 publication Critical patent/FR2916352B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0703663A 2007-05-23 2007-05-23 USE OF A NON-PEPTIDE ANTAGONIST OF BRADYKININ B1 RECEPTOR FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE PREVENTION OR TREATMENT OF ARTERIAL HYPERTENSION. Expired - Fee Related FR2916352B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0703663A FR2916352B1 (en) 2007-05-23 2007-05-23 USE OF A NON-PEPTIDE ANTAGONIST OF BRADYKININ B1 RECEPTOR FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE PREVENTION OR TREATMENT OF ARTERIAL HYPERTENSION.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0703663A FR2916352B1 (en) 2007-05-23 2007-05-23 USE OF A NON-PEPTIDE ANTAGONIST OF BRADYKININ B1 RECEPTOR FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE PREVENTION OR TREATMENT OF ARTERIAL HYPERTENSION.

Publications (2)

Publication Number Publication Date
FR2916352A1 FR2916352A1 (en) 2008-11-28
FR2916352B1 true FR2916352B1 (en) 2009-07-31

Family

ID=38727933

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0703663A Expired - Fee Related FR2916352B1 (en) 2007-05-23 2007-05-23 USE OF A NON-PEPTIDE ANTAGONIST OF BRADYKININ B1 RECEPTOR FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE PREVENTION OR TREATMENT OF ARTERIAL HYPERTENSION.

Country Status (1)

Country Link
FR (1) FR2916352B1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041785B1 (en) * 1996-08-19 2006-05-09 UNIVERSITé DE SHERBROOKE B1-bradykinin receptor antagonists and use thereof
FR2822827B1 (en) * 2001-03-28 2003-05-16 Sanofi Synthelabo NOVEL N- (ARYLSULFONYL) BETA-AMINOACIDS DERIVATIVES COMPRISING A SUBSTITUTED AMINOMETHYL GROUP, THEIR PREPARATION METHOD AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
WO2006017938A1 (en) * 2004-08-19 2006-02-23 UNIVERSITé DE SHERBROOKE New peptidic and peptidoid bradykinin b1 receptor antagonists and uses thereof

Also Published As

Publication number Publication date
FR2916352A1 (en) 2008-11-28

Similar Documents

Publication Publication Date Title
FR15C0046I2 (en) DRUGS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
FR2907677B1 (en) USE OF A POLYSILOXANE / POLYUREE BLOCK COPOLYMER FOR THE TREATMENT OF HAIR
FR2867778B1 (en) USE OF INDAZOLECARBOXAMIDE DERIVATIVES FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT AND PREVENTION OF MALARIA
MA30128B1 (en) PHARMACEUTICAL COMBINATIONS OF ANGIOTENSIN RECEPTOR ANTAGONIST AND CIP INHIBITOR
SG163564A1 (en) Kinin antagonists for treating bladder dysfunction
HUS1800044I1 (en) Angiotensin II receptor antagonist for the treatment of hypertension in cats
FR2902324B1 (en) USE OF ELLAGIC ACID FOR THE TREATMENT OF CANITIA
FR2926215B1 (en) SYSTEM FOR PREVENTING ANEVISM OR THE LIKE IN A BLOOD VESSEL
FR2903003B1 (en) USE OF A C-GLYCOSIDE DERIVATIVE TO ENHANCE THE BARRIER FUNCTION OF THE SKIN
FR2910325B1 (en) USE OF LUPULONES FOR THE PREVENTION AND THERAPY OF COLORECTAL CANCER.
FR2915102B1 (en) USE OF ANTI-CXCR4 ANTIBODY FOR THE TREATMENT OF CANCER
FR2919501B1 (en) USE OF HESPERIDINE OR ONE OF ITS DERIVATIVES FOR THE PREVENTION AND / OR TREATMENT OF RELEASED SKINS
FR2902010B1 (en) USE OF 1.7 DIMETHYLXANTHINE FOR THE MANUFACTURE OF A NON-ANXIOGENIC PSYCHOANALEPTIC MEDICAMENT FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDER
FR2942962B1 (en) USE OF A DIHYDROCHALCONE OR ONE OF ITS DERIVATIVES FOR IMPROVING THE SURFACE CONDITION OF A FRAGILIZED AND / OR ALTERED SKIN
FR2896422B1 (en) DRAINAGE SYSTEM FOR THE TREATMENT OF HYDROCEPHALY
FR2919187B1 (en) USE OF YEAST SKIN FOR THE TREATMENT AND / OR PREVENTION OF HYPERINSULINEMIA.
FR2930247B1 (en) ONIUM SALTS AND THEIR USE FOR THE DETECTION AND DETERMINATION OF METALS.
FR2916352B1 (en) USE OF A NON-PEPTIDE ANTAGONIST OF BRADYKININ B1 RECEPTOR FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE PREVENTION OR TREATMENT OF ARTERIAL HYPERTENSION.
FR2896678B1 (en) SET CONFIGURE FOR EXFOLIATING THE SKIN
MA29720B1 (en) USE OF IVABRADINE FOR THE PRODUCTION OF MEDICAMENTS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION
FR2899097B1 (en) HELP SYSTEM FOR A PASSING PERSON
FR3005419B1 (en) USE OF A COMBINATION OF TWO COMPOUNDS FOR THE TREATMENT AND / OR PREVENTION OF BONE DISORDERS
FR2895239B1 (en) USE OF AN ANTAGONIST OF NEUROPEPTIDE Y FOR THE CARE OF DAMAGED OR SENSITIVE LIPS
FR2868307B1 (en) USE OF BETA-ENDORPHINE FOR THE TREATMENT OF WRINKLES
FR2919803B1 (en) USE OF A NON-PEPTIDE RECEPTOR B1 ANTAGONIST FOR THE PREPARATION OF MEDICAMENTS USEFUL IN THE TREATMENT OF OBESITY AND OBESITY OR DIABETES PATHOLOGIES

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20130131